Thrombophilic Risk Factors in Patients with Central Retinal Vein Occlusion
- 1 January 2001
- journal article
- review article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 86 (09) , 722-726
- https://doi.org/10.1055/s-0037-1616130
Abstract
Few and contrasting data are available on the prevalence of hemostatic risk factors in patients with central retinal vein occlusion (CRVO). Aim of this study was to investigate the metabolic and inherited risk factors for venous thrombosis in 100 CRVO patients (age: 59 yrs; range 18-77) and in 100 controls (age: 56 yrs; range 18-84). In patients homocysteine (Hcy) levels were significantly higher than in controls and were affected by the C677T methylenetetrahydrofolate reductase (MTHFR) polymorphism (p <0.001). The prevalences of activated protein C resistance (APCR), factor V Leiden positivity, elevated PAI-1 and Lp(a) levels were significantly higher in patients with respect to controls. At multivariate analysis, only hyperhomocysteinemia (OR 11, 95% CI 3.6-36.2; p <0.0001) and elevated PAI-1 levels (OR 8.9, 95% CI 3.5-41.3; p <0.01), in addition to hypertension (OR 40.5, 95% CI 8.6-188.8; p <0.00001) and hypercholesterolemia (OR 3.1, 95% CI 1.6-20.5; p <0.05), were independent risk factors for CRVO. These data demonstrate a potential role of hemostatic risk factors in the pathophysiology of CRVO.Keywords
This publication has 18 references indexed in Scilit:
- Markers of thrombophilia in retinal vein thrombosisActa Ophthalmologica Scandinavica, 2000
- The Prothrombin Gene G20210A Mutation and the Platelet Glycoprotein IIIa Polymorphism PlA2 in Patients with Central Retinal Vein OcclusionThrombosis Research, 1999
- Analysis of genetic polymorphisms related to thrombosis and other risk factors in patients with retinal vein occlusionBlood Coagulation & Fibrinolysis, 1998
- The 20210A allele of the prothrombin gene is not a risk factor for retinal vein occlusionBlood Coagulation & Fibrinolysis, 1998
- Activated Protein C Resistance, Factor V Leiden, and Central Retinal Vein Occlusion in Young AdultsArchives of Ophthalmology (1950), 1998
- ANTIPHOSPHOLIPID-PROTEIN ANTIBODIES ARE NOT AN UNCOMMON FEATURE IN RETINAL VENOUS OCCLUSIONSThrombosis Research, 1996
- Activated protein C resistance in young adults with central retinal vein occlusion.British Journal of Ophthalmology, 1996
- Role of Rheologic Factors in Patients with Acute Central Retinal Vein OcclusionOphthalmology, 1996
- A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular DiseaseJAMA, 1995
- CENTRAL RETINAL VEIN OCCLUSION IN YOUNG ADULTS (PAPILLOPHLEBITIS)Retina, 1992